SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-006743
Filing Date
2024-03-06
Accepted
2024-03-06 09:23:54
Documents
17
Period of Report
2024-03-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20240305c_8k.htm   iXBRL 8-K 34205
2 EXHIBIT 10.1 ex_635311.htm EX-10.1 26151
3 EXHIBIT 99.1 ex_635326.htm EX-99.1 14835
  Complete submission text file 0001437749-24-006743.txt   221839

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20240304.xsd EX-101.SCH 3409
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20240304_def.xml EX-101.DEF 11424
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20240304_lab.xml EX-101.LAB 15310
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20240304_pre.xml EX-101.PRE 11584
18 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20240305c_8k_htm.xml XML 2852
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 24724540
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)